NIH Funding · FY2024
Total Funding
$1.3M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#10,734
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.3M across 2 grants · National rank #10734.
Top grants by award amount
Glen Coburn's NIH grant portfolio, ranked by award amount.
- 5R44AI177015-02R44Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections$1Maward amount
- 5R43AI179443-02R43Discovery of antiviral inhibitors for the treatment of orthopoxvirus infections$300Kaward amount
Affiliation
Institutions that have administered grants for Glen Coburn.
Affiliated with Venatorx Pharmaceuticals, Inc. (PA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardVenatorx Pharmaceuticals, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
Related investigators
Other NIH-funded PIs frequently associated with Glen Coburn.
Explore further
Find collaborators for Glen Coburn
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Venatorx Pharmaceuticals, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →